Skip to content

Impact of post-meal walking on glycaemic variability in people with type 2 diabetes

Post-meal walking for people with type 2 diabetes to assess the effect on glycaemic variability

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000832774
Enrollment
35
Registered
2013-07-29
Start date
2013-08-20
Completion date
2014-07-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Practical initiatives that help people with type 2 diabetes achieve better blood sugar control are desperately needed. Persistently high blood sugar leads to oxidative stress and vascular disease. Although 30 minutes of daily physical activity is recommended, it is unclear how the timing of the activity affects blood sugar control. In people without diabetes, gentle walking after a meal substantially reduces the magnitude of blood sugar rises. Our aim is to test the effect of post-meal walking in people with type 2 diabetes using quantitative measures of blood sugar control (glycated haemoglobin, continuous glucose monitors) and compliance with activity advice (accelerometers). Quality of life and the ease with which the advice can be taken up will be assessed. Study findings will be used to inform population guidelines for type 2 diabetes with an emphasis on lessening the impact of disease progression and improving the long-term health of New Zealand adults.

Interventions

We will advise and support people with type 2 diabetes to adhere to two physical activity regimens in a crossover design, each regimen lasting two weeks with a one month washout between treatment periods. One regimen is to follow the established Diabetes New Zealand guideline of “30 minutes brisk walking most days”. The other regimen is to undertake three 10-minute walks per day, each walk commencing shortly after breakfast, lunch and dinner. Following the crossover period of the trial, partici

We will advise and support people with type 2 diabetes to adhere to two physical activity regimens in a crossover design, each regimen lasting two weeks with a one month washout between treatment periods. One regimen is to follow the established Diabetes New Zealand guideline of “30 minutes brisk walking most days”. The other regimen is to undertake three 10-minute walks per day, each walk commencing shortly after breakfast, lunch and dinner. Following the crossover period of the trial, participants will be invited to continue with the post-meal walking for a further three months with continuing support and motivation from the study investigators. The justification for post-meal walking is evidence of a reduction in peak glucose concentrations compared with being sedentary after eating in pre-diabetics, as measured by parameters captured with continuous glucose monitoring systems (CGMS). The 3-month follow-up will allow for changes in glycated haemoglobin, a longer-term measure of glycaemic control to be assessed, as well as a better understanding of supported environments in disease management. The study’s quantitative framework is a valuable opportunity to concurrently assess qualitative impacts on diabetes management and treatment.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Type 2 diabetes

Exclusion criteria

Unable to walk for 30 minutes per day

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 12, 2026